Bumper Offer - Urjas oil Just @ Rs. 1
Xigduo IR 5/1000 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Diabetes Type 2, Diabetes.
Medical history of the patient along with age and gender determines the dosage of Xigduo IR 5/1000 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Xigduo IR 5/1000 Mg Tablet are Stomach Upset, Difficulty urinating. Besides the aforementioned side effects, there are other adverse effects of Xigduo IR 5/1000 Mg Tablet as well, which are listed below. Such side effects of Xigduo IR 5/1000 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Xigduo IR 5/1000 Mg Tablet is Mild for pregnant women and Moderate for women who are breastfeeding. In addition, Xigduo IR 5/1000 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Xigduo IR 5/1000 Mg Tablet related warnings section.
Xigduo IR 5/1000 Mg Tablet is contraindicated in people with pre-existing medical conditions like Bladder Cancer, Kidney Disease, Congestive Heart Failure (CHF) as it can result in adverse effects. Other conditions have been mentioned below in the Xigduo IR 5/1000 Mg Tablet contraindications section.
Additionally, Xigduo IR 5/1000 Mg Tablet may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Xigduo IR 5/1000 Mg Tablet, it is important to know that it is safe while driving, and is habit-forming.
Xigduo IR 5/1000 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Xigduo IR 5/1000 Mg Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Xigduo IR 5/1000 Mg Tablet safe for pregnant women?
Pregnant women can consume [medicine]. Though Xigduo XR Tablet has mild side effects when taken during pregnany
Is the use of Xigduo IR 5/1000 Mg Tablet safe during breastfeeding?
Xigduo XR Tablet may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Xigduo XR Tablet, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Xigduo XR Tablet.
What is the effect of Xigduo IR 5/1000 Mg Tablet on the Kidneys?
Xigduo XR Tablet does not damage the kidneys.
What is the effect of Xigduo IR 5/1000 Mg Tablet on the Liver?
Xigduo XR Tablet is completely safe for the liver.
What is the effect of Xigduo IR 5/1000 Mg Tablet on the Heart?
There are no any side effects of Xigduo XR Tablet for the heart.
Xigduo IR 5/1000 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Xigduo IR 5/1000 Mg Tablet unless your doctor advises you to do so -
Is this Xigduo IR 5/1000 Mg Tablet habit forming or addictive?
No, there is no any evidence that Xigduo IR 5/1000 Mg Tablet is addictive.
Interaction between Food and Xigduo IR 5/1000 Mg Tablet
There isn't any research available on the side effects of taking Xigduo IR 5/1000 Mg Tablet with food.
Interaction between Alcohol and Xigduo IR 5/1000 Mg Tablet
Consult your doctor before consuming alcohol while taking Xigduo IR 5/1000 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
